Daiwa Securities Group’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $55K | Sell |
2,564
-11,695
| -82% | -$251K | ﹤0.01% | 1058 |
|
2025
Q1 | $275K | Buy |
14,259
+11,825
| +486% | +$228K | ﹤0.01% | 900 |
|
2024
Q4 | $43K | Sell |
2,434
-225
| -8% | -$3.98K | ﹤0.01% | 1068 |
|
2024
Q3 | $58K | Hold |
2,659
| – | – | ﹤0.01% | 1055 |
|
2024
Q2 | $21K | Sell |
2,659
-69
| -3% | -$545 | ﹤0.01% | 1127 |
|
2024
Q1 | $11K | Hold |
2,728
| – | – | ﹤0.01% | 1156 |
|
2023
Q4 | $7K | Hold |
2,728
| – | – | ﹤0.01% | 1179 |
|
2023
Q3 | $5K | Hold |
2,728
| – | – | ﹤0.01% | 1159 |
|
2023
Q2 | $7K | Hold |
2,728
| – | – | ﹤0.01% | 1149 |
|
2023
Q1 | $5K | Buy |
2,728
+1,918
| +237% | +$3.52K | ﹤0.01% | 1149 |
|
2022
Q4 | $3K | Buy |
810
+476
| +143% | +$1.76K | ﹤0.01% | 1198 |
|
2022
Q3 | $0 | Hold |
334
| – | – | ﹤0.01% | 1379 |
|
2022
Q2 | $0 | Hold |
334
| – | – | ﹤0.01% | 1404 |
|
2022
Q1 | $1K | Hold |
334
| – | – | ﹤0.01% | 1329 |
|
2021
Q4 | $1K | Hold |
334
| – | – | ﹤0.01% | 1353 |
|
2021
Q3 | $2K | Buy |
334
+179
| +115% | +$1.07K | ﹤0.01% | 1243 |
|
2021
Q2 | $1K | Hold |
155
| – | – | ﹤0.01% | 1206 |
|
2021
Q1 | $1K | Hold |
155
| – | – | ﹤0.01% | 1220 |
|
2020
Q4 | $1K | Buy |
+155
| New | +$1K | ﹤0.01% | 1199 |
|